Prevalence of Maternal-Risk Factors Related to Neonatal Abstinence Syndrome in a Commercial Claims Database: 2011-2015

Pharmacotherapy
Chintan V DaveAbraham Hartzema

Abstract

Despite the rising incidence of neonatal abstinence syndrome (NAS), data evaluating trends in maternal risk factors associated with NAS have not been available for recent years, a period characterized by declining opioid prescriptions. The objective of this study was to examine the prevalence of opioid- and non-opioid-related factors associated with NAS, and by mutually exclusive subgroups of deliveries without prescription-opioid use, with prescription-opioid use, and with opioid-use disorder (OUD). A cohort of pregnancies resulting in live births in a commercial claims data base in 2011-2015 was identified. Examples of maternal risk factors of interest included antepartum prescription-drug use (e.g., opioids, selective serotonin reuptake inhibitors [SSRIs], antipsychotics) and nonprescription-related factors (e.g., smoking, OUD). A total of 659 cases of NAS among 621,940 deliveries was identified. Among NAS deliveries, prescription opioids were the most commonly used drug-class (39.0%). Adjusted relative risk (RR) for NAS was 5.43 (95% confidence interval [CI] 4.25-6.95), followed by SSRIs (20.9%; RR 3.16, CI 2.43-4.11); OUD was noted in 36.3% of the deliveries (RR 40.74, CI 22.64-73.32). In the subgroup of deliveries without...Continue Reading

References

Oct 5, 2010·Drug and Alcohol Review·Lucy BurnsRichard P Mattick
Dec 15, 2010·The New England Journal of Medicine·Hendrée E JonesGabriele Fischer
Apr 25, 2012·Obstetrics and Gynecology·Andreea A CreangaLeonard J Paulozzi
May 2, 2012·JAMA : the Journal of the American Medical Association·Stephen W PatrickMatthew M Davis
Jul 31, 2013·Annals of Epidemiology·Richard A EpsteinWilliam O Cooper
Jul 26, 2014·The Journal of Perinatal & Neonatal Nursing·Karen C DʼApolito
Jul 30, 2014·Pediatrics·Prabhakar Kocherlakota
Apr 29, 2015·The New England Journal of Medicine·Veeral N ToliaAlan R Spitzer
May 1, 2015·Journal of Perinatology : Official Journal of the California Perinatal Association·S W PatrickW O Cooper
Jan 20, 2016·The Annals of Pharmacotherapy·Vonya N StreetzDennis F Thompson
Mar 15, 2016·Journal of Addiction Medicine·Karol Kaltenbach, Hendree E Jones
Aug 12, 2016·MMWR. Morbidity and Mortality Weekly Report·Jean Y KoWanda D Barfield
Dec 13, 2016·JAMA Pediatrics·Nicole L G VillapianoStephen W Patrick
Dec 22, 2016·The New England Journal of Medicine·Karen McQueen, Jodie Murphy-Oikonen
May 14, 2017·Pharmacotherapy·Xi WangAlmut G Winterstein
Jul 7, 2017·MMWR. Morbidity and Mortality Weekly Report·Gery P GuyDeborah Dowell
Jul 8, 2017·The Journal of Rural Health : Official Journal of the American Rural Health Association and the National Rural Health Care Association·Joshua D BrownJeffery C Talbert
Aug 5, 2017·BMJ : British Medical Journal·Krista F HuybrechtsElisabetta Patorno
Mar 25, 2018·Pediatrics·Tyler N A WinkelmanStephen W Patrick

❮ Previous
Next ❯

Citations

Feb 21, 2021·Journal of Perinatology : Official Journal of the California Perinatal Association·Rachana SinghUNKNOWN for PNQIN Collaborative of Massachusetts

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here